Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Leigha Senter

Professor, Genetic Counselor

Ohio State University

United States

Research Interests

Explore related searches

Professors in United States Professors in Epidemiology Epidemiology professors in United States

Articles (17)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (6)

Tasleem Padamsee

Associate Professor

Ohio State University

UNITED STATES

View details

Ewa Grzybowska

Professor

Maria Sklodowska-Curie National Research Institute of Oncology

POLAND

View details

Carolyn J. Presley

Ohio State University

UNITED STATES

View details

Kelly Metcalfe

Professor and Associate Dean, Research & External Relations

University of Toronto

CANADA

View details

Amber Aeilts

Assistant Professor, Genetic Counselor

Ohio State University

UNITED STATES

View details

Amanda Toland

Ohio State University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Leigha Senter

Research Interests

Explore related searches

Articles (17)

A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients with Metastatic Breast Cancer: Primary Results of a Prospective Intervention Trial

Lynch syndrome in the general population: low clinical utility of genomic screening for PMS2 pathogenic variants

A video intervention to improve patient understanding of tumor genomic testing in patients with cancer

Does the choice of platinum doublet matter? A study to evaluate the impact of platinum doublet choice for treatment of platinum-sensitive ovarian cancer recurrence on the development of future PARP inhibitor and platinum resistance.

Germline Variants of Uncertain Significance in Gynecologic Oncology Patients

Germline and Somatic Testing for Ovarian Cancer: An SGO Clinical Practice Statement

Is it time to add<i> BRCA1</i> promoter methylation testing in the arsenal of ovarian cancer diagnostic tools?

Correction to: Survival from breast cancer in women with a BRCA2 mutation by treatment.

The risks of cancer in older women with BRCA pathogenic variants: How far have we come?

Patient Understanding of Tumor Genomic Testing: A Quality Improvement Effort

A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer

BRCAShare-Assessment of an animated digital message for intrafamilial communication of pathogenic variant positive test results: A feasibility study

Development of a web-based, theory-guided narrative intervention for women at elevated risk for breast cancer

Genetic counseling and testing for females at elevated risk for breast cancer: Protocol for the randomized controlled trial of the Know Your Risk intervention

Hereditary/Familial Ovarian Cancer: Testing Principles and Risk Management

Recurrence rate in early-stage epithelial ovarian cancer: Is there a role for upfront maintenance with PARP inhibitors in stages I and II?

Universal testing - Should it be that hard? Probably. If you're doing it right

Collaborators (6)

Tasleem Padamsee

Ewa Grzybowska

Carolyn J. Presley

Kelly Metcalfe

Amber Aeilts

Amanda Toland

Make your next move.